Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Report looks at timeliness of FDA approvals

Although FDA drug and device approval time is improving, consistency needs to be key.

The time it takes the FDA to approve drugs and medical devices is improving, according to a PricewaterhouseCooper report, the Regulatory Affairs Professionals Society reported.

In 2012 it took the agency half the time, seven months, for premarket approval applications than it did three years earlier in 2009, when it took 14 months, according to the report.

The PricewaterhouseCooper report, "The FDA and industry: A recipe for collaborating in the New Health Economy," explained that as a result, new products are reaching customers more quickly.

But, one problem, according to the article is consistency.

"For devices, for example, FDA actually got worse since 2008, when it approved devices subject to priority review in just 6 months," according to the article. "A year later, it approved those devices in 16 months. As of 2012, it approved them in 8 months—still higher than its 2008 average."

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?